Sweden
· Delayed Price · Currency is SEK Vaxxa AB Statistics
Total Valuation
Vaxxa AB has a market cap or net worth of SEK 38.97 million. The enterprise value is 31.88 million.
| Market Cap | 38.97M |
| Enterprise Value | 31.88M |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
| Earnings Date | Feb 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vaxxa AB has 33.31 million shares outstanding. The number of shares has decreased by -97.98% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 33.31M |
| Shares Change (YoY) | -97.98% |
| Shares Change (QoQ) | +4.32% |
| Owned by Insiders (%) | 2.08% |
| Owned by Institutions (%) | n/a |
| Float | 32.61M |
Valuation Ratios
The trailing PE ratio is 136.25.
| PE Ratio | 136.25 |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| PB Ratio | 2.23 |
| P/TBV Ratio | 3.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 111.48 |
| EV / Sales | 0.35 |
| EV / EBITDA | 7.34 |
| EV / EBIT | 81.75 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.14 |
| Quick Ratio | 2.08 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | n/a |
| Interest Coverage | 11.14 |
Financial Efficiency
Return on equity (ROE) is 2.03% and return on invested capital (ROIC) is 1.56%.
| Return on Equity (ROE) | 2.03% |
| Return on Assets (ROA) | 1.17% |
| Return on Capital (ROIC) | 1.56% |
| Revenue Per Employee | 13.20M |
| Profits Per Employee | 40,857 |
| Employee Count | 6 |
| Asset Turnover | 4.43 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +16.00% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 37.38 |
| Average Volume (20 Days) | 93,431 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vaxxa AB had revenue of SEK 92.40 million and earned 286,000 in profits. Earnings per share was 0.01.
| Revenue | 92.40M |
| Gross Profit | 7.19M |
| Operating Income | 390,000 |
| Pretax Income | 286,000 |
| Net Income | 286,000 |
| EBITDA | 4.34M |
| EBIT | 390,000 |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 7.63 million in cash and 540,000 in debt, giving a net cash position of 7.09 million or 0.21 per share.
| Cash & Cash Equivalents | 7.63M |
| Total Debt | 540,000 |
| Net Cash | 7.09M |
| Net Cash Per Share | 0.21 |
| Equity (Book Value) | 17.48M |
| Book Value Per Share | 0.52 |
| Working Capital | 6.92M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 7.78%, with operating and profit margins of 0.42% and 0.31%.
| Gross Margin | 7.78% |
| Operating Margin | 0.42% |
| Pretax Margin | 0.31% |
| Profit Margin | 0.31% |
| EBITDA Margin | 4.70% |
| EBIT Margin | 0.42% |
| FCF Margin | n/a |
Dividends & Yields
Vaxxa AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 97.98% |
| Shareholder Yield | 97.98% |
| Earnings Yield | 0.73% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 14, 2024. It was a reverse split with a ratio of 0.01.
| Last Split Date | Mar 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
Vaxxa AB has an Altman Z-Score of 7.62.
| Altman Z-Score | 7.62 |
| Piotroski F-Score | n/a |